Found: 5
Select item for more details and to access through your institution.
Recombinant probiotic Lactococcus lactis delivering P62 mitigates moderate colitis in mice.
- Published in:
- Frontiers in Microbiology, 2024, p. 01, doi. 10.3389/fmicb.2024.1309160
- By:
- Publication type:
- Article
Synergistic synbiotic containing fructooligosaccharides and Lactobacillus delbrueckii CIDCA 133 alleviates chemotherapy-induced intestinal mucositis in mice.
- Published in:
- World Journal of Microbiology & Biotechnology, 2023, v. 39, n. 9, p. 1, doi. 10.1007/s11274-023-03679-0
- By:
- Publication type:
- Article
Therapeutic effects and the impact of statins in the prevention of ulcerative colitis in preclinical models: A systematic review.
- Published in:
- Fundamental & Clinical Pharmacology, 2023, v. 37, n. 3, p. 493, doi. 10.1111/fcp.12859
- By:
- Publication type:
- Article
Lactobacillus delbrueckii CIDCA 133 Ameliorates Chemotherapy-Induced Mucositis by Modulating Epithelial Barrier and TLR2/4/Myd88/NF-κB Signaling Pathway.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.858036
- By:
- Publication type:
- Article
Lyophilized Symbiotic Mitigates Mucositis Induced by 5-Fluorouracil.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.755871
- By:
- Publication type:
- Article